While there is a lot of noise in the market, for those of you who want to buy and hold their positions for a few years, here is a list of my top 10 in alphabetical order. One thing to notice is the large portion of US names, despite me investing in the UK for […]
First of all, Happy New Year to all investors out there. Hope 2026 brings you lots of success. So on to the update for Q4 and a few thoughts on 2025. The porfolio performed reasonably well during Q4, delivering average return of 2.8% vs negative 2.2% for FTSE AIMs and 2.6% for S&P500. A few […]
One of the names which I initiated positions in a couple of months ago(Advanced Medical Solutions) had a bid speculation today. This is not at all surprising as they had one earlier in the year too. Clearly there are a lot of private equity shops lurking around trying to take out solid undervalued UK AIMs […]
Over the last couple of weeks I initiated a position in Ondine Biomedical(OBI). Ondine is a s a Canadian life sciences company focused on developing and commercializing light-based, non-antibiotic antimicrobial therapies to prevent and treat infections in hospitals and other settings. Its core platform, called photodisinfection, uses a photosensitive agent activated by light to rapidly […]
While I no longer hold them, I still follow them closely for potential entry. Both had reasonable updates(revenue growth more than profitability) as the NIC contributions are starting to bite into these labour intensive sectors. I am keenly following what will come out of the budget as there is significant speculation that there will be […]
Generally good update. The business is doing well in a challenging environment, but the fact that they have production facilities in multiple countries helps a lot with the tariff malarkey. None the less, I sold about 1/3 of my shares on the day, as usually Volex rallies strongly on results and then sells off(I am […]
Yesterday(20th Nov), Mitie updated the market with its H1 26 results. I thought the results were excellent (organic revenue growth of 6.4%, overall growth of 10.4%), with all levels growing despite increases in costs(NIC) which I suspect over the long term would roll over into pricing as contracts renew. The pipeline seems excellent(bidding pipeline is […]
Very disappointing trading update from Hilton Foods. While this has been a long term holding of mine, it is also the one which has gone the most since purchase. This is the second time in a few months that they updated the market negatively. I have a 3 strikes out rule and this is the […]
Over the past several weeks I’ve done a few more trades. I completely sold out of Alumasc prior to the results(which I am extremely pleased about as it come off by about 20% since then). I think the building business is quite tough in the moment(another one of my holdings Billington had to close down […]
2 out of the 3 beat expectations and the share price action reflected this. While Meta’s core results were great, the significant CAPEX spending on AI is spooking investors. I would likely use this opportunity to top up if the shares drop any further. While I am not a big fan of Google’s Gemini(Open AI […]